Research and Markets: Chronic Plaque Psoriasis – Pipeline Review, H2 2012

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tmwql4/chronic_plaque) has announced the addition of Global Markets Direct's new report "Chronic Plaque Psoriasis - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Chronic Plaque Psoriasis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chronic Plaque Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Plaque Psoriasis.

Scope

- A snapshot of the global therapeutic scenario for Chronic Plaque Psoriasis.

- A review of the Chronic Plaque Psoriasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Chronic Plaque Psoriasis pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

Link:
Research and Markets: Chronic Plaque Psoriasis - Pipeline Review, H2 2012